A Randomized Controlled Trial of Allopurinol in Patients With Peripheral Arterial Disease


BACKGROUND Patients with peripheral arterial disease (PAD) are limited by intermittent claudication in the distance they can walk. Allopurinol has been shown in coronary arterial disease to prolong exercise before angina occurs, likely by prevention of oxygen wastage in tissues and reduction of harmful oxidative stress. METHODS In this study we evaluated… (More)
DOI: 10.1016/j.cjca.2015.05.010

7 Figures and Tables


  • Presentations referencing similar topics